Literature DB >> 20327411

Trifluoperazine and Pregnancy.

A J Moriarty, M R Nance.   

Abstract

Entities:  

Year:  1963        PMID： 20327411      PMCID： PMC1921108     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  9 in total

Review 1.  Effects of antipsychotics on the unborn child: what is known and how should this influence prescribing?

Authors:  H B Pinkofsky
Journal:  Paediatr Drugs       Date:  2000 Mar-Apr       Impact factor: 3.022

2.  Arthrogryposis Multiplex Congenita with Potter's Syndrome.

Authors:  W Feldman
Journal:  Can Med Assoc J       Date:  1969-11-29       Impact factor: 8.262

3.  The use of central nervous system active drugs during pregnancy.

Authors:  Bengt Källén; Natalia Borg; Margareta Reis
Journal:  Pharmaceuticals (Basel)       Date:  2013-10-10

Review 4.  Antipsychotic therapy during early and late pregnancy. A systematic review.

Authors:  Salvatore Gentile
Journal:  Schizophr Bull       Date:  2008-09-11       Impact factor: 9.306

Review 5.  A risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy.

Authors:  P Mazzotta; L A Magee
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

6.  Congenital malformations following phenothiazine administration during pregnancy.

Authors:  D J Vince
Journal:  Can Med Assoc J       Date:  1969-01-25       Impact factor: 8.262

7.  Adverse effects of antipsychotic agents.

Authors:  G M Simpson; E H Pi; J J Sramek
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

8.  The potential risks of commonly prescribed antipsychotics: during pregnancy and lactation.

Authors:  Mohammad Masud Iqbal; Alka Aneja; Atiq Rahman; James Megna; Wanda Freemont; Mohammed Shiplo; Nikil Nihilani; Kathy Lee
Journal:  Psychiatry (Edgmont)       Date:  2005-08

Review 9.  Antipsychotic use in pregnancy. What are the best treatment options?

Authors:  M Trixler; T Tényi
Journal:  Drug Saf       Date:  1997-06       Impact factor: 5.606
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.